| abstract |
An object of the present invention is to provide an effective therapeutic agent for ophthalmic diseases, particularly ocular diseases associated with angiogenesis, macular hole, macular epithelium, visual impairment, vitreous opacification or fundus hemorrhage, decreased retinal sensitivity, and eye strain. An ophthalmic treatment for ophthalmic diseases containing phytoalexin such as transresveratrol, which is clathrated and solubilized with cyclodextrin. [Selection figure] None |